BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,318 | -72.7% | 4,078 | -28.2% | 0.00% | -100.0% |
Q2 2023 | $37,823 | +130324.1% | 5,679 | +271.4% | 0.00% | 0.0% |
Q1 2023 | $29 | +163.6% | 1,529 | +205.2% | 0.00% | – |
Q4 2022 | $11 | -99.9% | 501 | -59.9% | 0.00% | – |
Q3 2022 | $15,000 | -57.1% | 1,250 | -52.4% | 0.00% | -100.0% |
Q2 2022 | $35,000 | -49.3% | 2,628 | -20.8% | 0.00% | 0.0% |
Q1 2022 | $69,000 | -27.4% | 3,317 | -29.3% | 0.00% | -50.0% |
Q4 2021 | $95,000 | -33.6% | 4,690 | +0.1% | 0.00% | -50.0% |
Q3 2021 | $143,000 | +521.7% | 4,686 | +475.0% | 0.00% | +300.0% |
Q2 2021 | $23,000 | -68.9% | 815 | -52.5% | 0.00% | 0.0% |
Q1 2021 | $74,000 | +1750.0% | 1,716 | +1850.0% | 0.00% | – |
Q4 2020 | $4,000 | -94.8% | 88 | -95.0% | 0.00% | -100.0% |
Q3 2020 | $77,000 | -75.6% | 1,770 | -70.3% | 0.00% | -92.3% |
Q2 2020 | $316,000 | +10433.3% | 5,963 | +4910.9% | 0.01% | – |
Q1 2020 | $3,000 | -66.7% | 119 | -90.8% | 0.00% | -100.0% |
Q3 2019 | $9,000 | +125.0% | 1,291 | +243.4% | 0.00% | – |
Q2 2019 | $4,000 | 0.0% | 376 | -66.5% | 0.00% | – |
Q4 2018 | $4,000 | +100.0% | 1,122 | +247.4% | 0.00% | – |
Q3 2018 | $2,000 | +100.0% | 323 | +223.0% | 0.00% | – |
Q1 2018 | $1,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 40,000 | $836,000 | 1.01% |
ACT CAPITAL MANAGEMENT, LLC | 20,000 | $418,000 | 0.44% |
Knoll Capital Management, LLC | 20,000 | $418,000 | 0.26% |
Artemis Investment Management LLP | 1,428,228 | $29,855,000 | 0.24% |
Rubric Capital Management LP | 268,528 | $5,615,000 | 0.20% |
Virtus ETF Advisers LLC | 7,713 | $161,000 | 0.07% |
BOOTHBAY FUND MANAGEMENT, LLC | 107,700 | $2,252,000 | 0.05% |
PDT Partners, LLC | 28,031 | $586,000 | 0.05% |
AllSquare Wealth Management LLC | 3,162 | $66,000 | 0.04% |
Hennion & Walsh Asset Management, Inc. | 35,221 | $736,000 | 0.04% |